Coldwell Banker Real Estate LLC has launched a new national advertising campaign called 'The Letter' during the 2026 football season on a streaming service. The campaign celebrates the brand's 120th anniversary by telling the story of one family living in the same home across three generations, highlighting the emotional value of homes beyond their market price. The campaign includes a 60-second main spot and shorter 15-second clips, emphasizing the life moments that make a house a home. This initiative reflects Coldwell Banker's long history of helping families find homes where their lives unfold, reinforcing the emotional connection people have with their living spaces.
Coldwell Banker’s 120th anniversary campaign is the subject, with Pluang’s Real Estate sector data providing market context. For readers following Real Estate stocks, here is Pluang's market snapshot as of Sep 15, 2026 02:12 WIB: Among 22 priced US Real Estate stocks, 11 rose and 11 fell. Alexandria Real Estate Equities Inc (ARE) gained 2.13% to USD 52.23, Extra Space Storage, Inc. (EXR) increased 1.51% to USD 139.72, while Iron Mountain Inc (IRM) declined 1.39% to USD 113.58.
Fortrea Holdings and Omico have formed a partnership to enhance precision oncology research in Australia by linking cancer patients to biomarker-matched clinical trials. This collaboration combines Fortrea's oncology trial expertise with Omico's Prec...
Fortrea Holdings Inc and Omico have formed a partnership to accelerate precision oncology research in Australia by connecting cancer patients to biomarker-driven clinical trials. The collaboration combines Fortrea's expertise in oncology clinical tri...
Fortrea Holdings and Omico have formed a partnership to accelerate precision oncology research in Australia by combining Fortrea's clinical trial expertise with Omico's Precision Oncology Screening Platform (PrOSPeCT). This collaboration aims to impr...
Fortrea Holdings Inc and Omico have formed a partnership to enhance precision oncology research in Australia by matching cancer patients with biomarker-driven clinical trials. This collaboration combines Fortrea's expertise in oncology clinical trial...
Fortrea Holdings and Omico have formed a partnership to accelerate precision oncology research by improving biomarker-based clinical trial planning and patient recruitment in Australia. The collaboration leverages Fortrea's clinical trial expertise a...
